Which statement best explains why electroconvulsive therapy (ECT) is effective in treating unipolar depression?

Which statement best explains why electroconvulsive therapy (ECT) is effective in treating unipolar depression?

• A. ECT increases norepinephrine and serotonin activity
• B. The reasons for ECT's effectiveness are not well understood
• C. ECT mimics the effects of cognitive therapy to eliminate negative thoughts
• D. ECT has a relaxing effect, which promotes a sense of well-being

Answer: (B)

ECT is known to be an effective, often rapid, treatment for severe unipolar depression, especially when other treatments have failed. But the exact way it produces these benefits isn’t fully understood. Researchers have proposed several plausible mechanisms—such as changes in brain chemistry (including monoamines like norepinephrine and serotonin), alterations in neurotrophic factors and neuroplasticity, and shifts in the functioning of neural circuits linking mood-regulating regions of the brain. Yet none of these explanations has been proven to capture the whole picture, and it’s likely that multiple processes contribute. That ambiguity is why the statement that the reasons for ECT’s effectiveness are not well understood is the best answer. It reflects the current scientific view that, despite clear clinical benefits, there isn’t a single, definitive mechanism established. The other ideas—attributing efficacy to a specific increase in monoamines, claiming it mimics cognitive therapy, or simply noting a relaxing effect—don’t fit as well. They either oversimplify or mischaracterize what ECT does, whereas recognizing the lack of a single confirmed mechanism aligns with the broad, ongoing research and clinical reality.

ECT is known to be an effective, often rapid, treatment for severe unipolar depression, especially when other treatments have failed. But the exact way it produces these benefits isn’t fully understood. Researchers have proposed several plausible mechanisms—such as changes in brain chemistry (including monoamines like norepinephrine and serotonin), alterations in neurotrophic factors and neuroplasticity, and shifts in the functioning of neural circuits linking mood-regulating regions of the brain. Yet none of these explanations has been proven to capture the whole picture, and it’s likely that multiple processes contribute.

That ambiguity is why the statement that the reasons for ECT’s effectiveness are not well understood is the best answer. It reflects the current scientific view that, despite clear clinical benefits, there isn’t a single, definitive mechanism established.

The other ideas—attributing efficacy to a specific increase in monoamines, claiming it mimics cognitive therapy, or simply noting a relaxing effect—don’t fit as well. They either oversimplify or mischaracterize what ECT does, whereas recognizing the lack of a single confirmed mechanism aligns with the broad, ongoing research and clinical reality.